Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Medical Science of Ukraine (MSU)Open Access

Endothelial Monocyte-Activating Polypeptide-Ii as a Possible Diagnostic and Prognostic Factor of Diabetic Retinopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

ASA.V. Serdiuk

Discussion

Loading...

Member takes

Overview

Observational analysis found elevated EMAP-II levels in diabetic retinopathy stages, suggesting it as a blood biomarker.

Key Points

  • Elevated EMAP-II levels correlate with the progression of diabetic retinopathy.
  • Patients with diabetic retinopathy had EMAP-II levels significantly higher than controls, with levels rising through NPDR, PPDR, and PDR stages.
  • Over a 2-year observation, higher EMAP-II levels increased the risk of diabetic retinopathy progression by 2.0-fold.
  • EMAP-II serves as a potential predictive biomarker for diabetic retinopathy with significant accuracy and correlation to other metabolic indicators.

Cite This Study

A.V. Serdiuk (2025) studied this question.

synapsesocial.com/papers/68bb49bc6d6d5674bccff68ahttps://doi.org/10.32345/2664-4738.2.2025.04
View Full Paper
Ask AI
Bookmark
Share